API China will promote pharmaceutical technology innovation and product upgrade in ChinaNews Time：2019-06-03
API China (Hangzhou), as a renowned display and business platform covering the full industrial chain and full life cycle of China’s pharmaceutical industry, will work with leading pharmaceutical companies to promote pharmaceutical technology innovation and product upgrade in China.
Major exhibitors will include Mindray, Shinva, United Imaging, GE, Siemens, Philips, Yuyue, JD.COM, Omron, Foxconn, Intel, as well as major pharmaceutical groups in China such as Sinopharm, Shanghai Pharma and CR Pharmaceuticals.
As the most influential event in the global health industry, tHIS has been committed to providing global customers with all-round support in the Chinese market and maintaining the linkage between the global market and the Chinese market. Each year, it witnesses the advance of global health technology innovation and sheds light on the direction of the health industry.